Stocks Down Under Videos

Get a 3-month FREE TRIAL to CONCIERGE now!

Concierge gives you timely BUY and SELL alerts on ASX-listed stocks

Noxopharm (ASX:NOX): Interview with CEO Graham Kelly

August 19, 2020

NOX, Noxopharm, video

We talked with Graham Kelly about Noxopharm’s clinical success with Veyonda and in particular its synergies with radiation therapy. Veyonda is a drug that seems to work in a wide variety of cancers.